Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin

Blood. 1997 May 15;89(10):3890-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Alkylating Agents* / adverse effects
  • Anemia, Aplastic / mortality
  • Anemia, Aplastic / therapy*
  • Antilymphocyte Serum* / adverse effects
  • Bone Marrow Transplantation* / adverse effects
  • Child
  • Child, Preschool
  • Cyclophosphamide* / adverse effects
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / etiology
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Life Tables
  • Male
  • Middle Aged
  • Prevalence
  • Survival Analysis
  • T-Lymphocytes / immunology*
  • Transplantation Conditioning* / adverse effects
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Alkylating Agents
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclophosphamide